LAVA Therapeutics N.V. (LVTX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

LAVA Therapeutics N.V.

NASDAQ: LVTX · Real-Time Price · USD
1.60
0.05 (3.23%)
At close: Oct 03, 2025, 3:58 PM
1.60
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT

LAVA Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
35.02M 44.23M 100.33M 151.01M
Short-Term Investments
41.56M 51.34M 32.53M 47.99M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
91K 319K 809K 902.43K
Receivables
n/a 1.7M 3.25M 734K
Inventory
n/a n/a n/a -48.83M
Other Current Assets
1.65M 1.63M n/a n/a
Total Current Assets
79.3M 98.9M 140.53M 154.76M
Property-Plant & Equipment
1.44M 2.49M 2.08M 2.21M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.53M 2.81M 2.89M 3.11M
Total Assets
80.83M 101.71M 143.43M 157.87M
Account Payables
2.72M 4.45M 3.96M 2.55M
Deferred Revenue
35M n/a 35M 1.73M
Short-Term Debt
4.89M 5.28M 4.64M n/a
Other Current Liabilities
-26.32M 482K 11.07M 6.75M
Total Current Liabilities
18.01M 14.94M 21.95M 5.02M
Long-Term Debt
n/a n/a n/a 4.28M
Other Long-Term Liabilities
n/a n/a n/a 5.03M
Total Long-Term Liabilities
35.08M 35.59M 35.43M 18.65M
Total Liabilities
53.09M 50.53M 57.38M 23.67M
Total Debt
5.28M 6.31M 5.45M 5.52M
Book Value
27.75M 51.18M 86.04M 134.19M
Book Value Per Share
1.03 1.91 3.32 6.79
Common Stock
3.72M 3.71M 3.71M 4.14M
Retained Earnings
-174.97M -148.07M -108.07M -89.26M
Comprehensive Income
-12.65M -10.9M -4.03M 1.33M
Shareholders Equity
27.75M 51.18M 86.04M 134.19M
Total Investments
41.56M 51.34M 32.53M 47.99M